Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ostrowski

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
Frontiers in Oncology|May 6, 2014
Protein kinase C Beta in the tumor microenvironment promotes mammary tumorigenesisJulie A Wallace, Jason R Pitarresi, Nandini Sharma, et al.
Oncogene|September 23, 2014
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growthH Mathsyaraja, K Thies, D A Taffany, et al.
Plos One|September 22, 2017
Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in alleleJinghai Wu, Xin Liu, Sunayana G Nayak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastomaJeffrey Wojton, Zhengtao Chu, Haritha Mathsyaraja, et al.
Cell Research|October 10, 2018
Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repairSteven T Sizemore, Manchao Zhang, Ju Hwan Cho, et al.
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Molecular Cancer Therapeutics|November 8, 2014
Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapiesWalter Hans Meisen, Samuel Dubin, Steven T Sizemore, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitorsPadma Akkapeddi, Takamitsu Hattori, Imran Khan, et al.
Scientific Reports|May 13, 2017
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivoHannah M Komar, Gregory Serpa, Claire Kerscher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2018
<i>Csf1r</i>-mApple Transgene Expression and Ligand Binding In Vivo Reveal Dynamics of CSF1R Expression within the Mononuclear Phagocyte SystemCatherine A Hawley, Rocio Rojo, Anna Raper, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Oncology|May 6, 2014
Protein kinase C Beta in the tumor microenvironment promotes mammary tumorigenesisJulie A Wallace, Jason R Pitarresi, Nandini Sharma, et al.
Oncogene|September 23, 2014
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growthH Mathsyaraja, K Thies, D A Taffany, et al.
Plos One|September 22, 2017
Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in alleleJinghai Wu, Xin Liu, Sunayana G Nayak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastomaJeffrey Wojton, Zhengtao Chu, Haritha Mathsyaraja, et al.
Cell Research|October 10, 2018
Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repairSteven T Sizemore, Manchao Zhang, Ju Hwan Cho, et al.
Oncotarget|November 18, 2015
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A Mace, Reena Shakya, Omar Elnaggar, et al.
Molecular Cancer Therapeutics|November 8, 2014
Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapiesWalter Hans Meisen, Samuel Dubin, Steven T Sizemore, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitorsPadma Akkapeddi, Takamitsu Hattori, Imran Khan, et al.
Scientific Reports|May 13, 2017
Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivoHannah M Komar, Gregory Serpa, Claire Kerscher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2018
<i>Csf1r</i>-mApple Transgene Expression and Ligand Binding In Vivo Reveal Dynamics of CSF1R Expression within the Mononuclear Phagocyte SystemCatherine A Hawley, Rocio Rojo, Anna Raper, et al.
Pageof 20